|
WO02090580A1
|
|
Identifying liver cancer by detecting aberrant expression of insulin like growth factor binding protein
|
|
AU7616101A
|
|
Molecular markers
|
|
AU4396201A
|
|
Nucleic acid molecule encoding a uterine estrogen agonist- inducible protein
|
|
WO0175099A1
|
|
Nucleic acid molecule encoding a uterine estrogen agonist-inducible protein
|
|
WO0170940A1
|
|
Genetic constructs for regulated expression of insulin
|
|
AU4209701A
|
|
Genetic constructs for regulated expression of insulin
|
|
US2003166519A1
|
|
Novel polynucleotides and polypeptides and uses therefor
|
|
AU3525501A
|
|
Assessment of the functional significance of a nucleotide sequence by subjectingthe reading frame data to data processing
|
|
WO0162958A1
|
|
Assessment of the functional significance of a nucleotide sequence by subjecting the reading frame data to data processing
|
|
AUPQ947000A0
|
|
Novel polynucleotide and polypeptide and uses therefor
|
|
AUPQ946900A0
|
|
Novel compositions and methods of using them
|
|
AUPQ947100A0
|
|
A nucleic acid molecule and uses therefor
|
|
AUPQ901700A0
|
|
Molecular markers
|
|
AUPQ856500A0
|
|
A method of treatment and/or prophylaxis
|
|
WO0071707A1
|
|
A method for the diagnosis and treatment of cancer and agents useful therefor
|
|
AU4525500A
|
|
A method for the diagnosis and treatment of cancer and agents useful therefor
|
|
GB0010690D0
|
|
An estrogen induced uterine cDNA, its isolation and medical uses
|
